Overview

Hercules Technology Growth Capital, Inc. (Nasdaq: HTGC) is the leading specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies. We offer growth capital to companies at all stages of development and specialize in venture debt in the forms of senior and subordinated working capital loans, senior revolving loans and bridge loans, venture leasing and select direct equity capital.

Our investment professionals understand how to structure financing solutions that balance the growth capital needs of our portfolio companies without sacrificing equity ownership.  The less dilutive financing solutions Hercules provides have proven to be attractive among portfolio companies as well as with the existing venture capital and private equity sponsors or shareholders.  Hercules is committed to building a diversified portfolio of private and public companies and transforming them into market leaders.

Hercules Technology Growth Capital, founded in 2003, consists of a seasoned team of fifteen managing directors and principals with more than 256 years of venture capital and specialty technology lending and investing experience, is headquartered in Palo Alto, California with additional offices in Boston, Massachusetts, Boulder, Colorado, Chicago, Illinois, and San Diego, California.

Recent Hercules News

Hercules Technology Growth Capital Secures New Credit Facility up to $300 Million with Initial Commitment from Wells Fargo Foothill of $50 Million Hercules Technology Growth Capital Announces Record Second Quarter 2008 Financial Results and Declares a $0.34 Q3 2008 Dividend Hercules Technology Growth Capital Announces Dividend of $0.34 per share, the Company’s Twelfth Consecutive Quarterly Dividend Hercules to Announce Second Quarter 2008 Financial Results and Quarterly Dividend Hercules Technology’s Kathy Conte to Speak on Life Sciences Financing Panel at Bio International Convention Hercules Technology Growth Capital to Ring Opening Bell at NASDAQ on June 9, 2008 Hercules Technology to Participate in SunTrust Robinson Humphrey Financial Services Unconference in New York City Hercules Technology’s Kathy Conte to be Featured Speaker at Association of Bioscience Financial Officers (ABFO) Event Hercules Technology’s Portfolio Company, Gomez, Inc., Announced Proposed $80.5 Million Initial Public Offering Hercules Technology’s Kathy Conte to Lead Life Sciences Workshop at TiEcon 2008 Conference in Santa Clara Hercules Technology’s Manuel Henriquez and David Lund to Present at Seventh Annual JMP Securities Research Conference Hercules Technology Provides $25 Million of Senior Debt to InfoLogix, Inc., a Leading Enterprise Mobility Solutions Provider Hercules Technology Expects Realized Gain from the Announced Acquisition of Sirtris Pharmaceuticals, Inc. by GlaxoSmithKline Hercules Technology Receives $58 Million in Liquidity through its SBIC at a Borrowing Rate of 5.471% Fixed for a Period of up to 10 Years from U.S. Small Business Administration